Bionano Genomics Inc
Research Bionano Genomics Inc (BNGO) on Bullrun: market cap USD 16.96M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBNGO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 16.96M
- Financial periodQ2 2026
- RevenueUSD 8.17M
- Net income-USD 7.42M
- Free cash flow-USD 4.67M
- Gross margin52.8%
Valuation Snapshot
latest market cap is USD 16.96M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 28.51M | -USD 26.40M | -USD 16.35M | 46.3% | -4.85 | USD 2.99M | USD 6.92M | USD 44.42M |
| FY2024 | USD 30.78M | -USD 112.02M | -USD 69.03M | 1.2% | -88.13 | USD 9.17M | USD 6.94M | USD 35.38M |
| FY2023 | USD 36.12M | -USD 232.49M | -USD 126.87M | 26.5% | -408.6 | USD 17.95M | USD 9.61M | USD 96.16M |
| FY2022 | USD 27.80M | -USD 132.60M | -USD 128.12M | 21.4% | -4.58 | USD 5.09M | USD 11.67M | USD 249.40M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 16.96M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 16.43M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 32.46M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 73.40M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 433.53M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 865.96M | n/a | n/a | n/a |
About Bionano Genomics Inc
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bionano Genomics Inc's market cap?
Bionano Genomics Inc's market capitalization is USD 16.96M.
What does Bionano Genomics Inc do?
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.